nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—SLC6A5—head—atopic dermatitis	0.0205	0.0808	CbGeAlD
Glycine—GLYATL2—head—atopic dermatitis	0.0174	0.0687	CbGeAlD
Glycine—SLC32A1—head—atopic dermatitis	0.0161	0.0634	CbGeAlD
Glycine—GLRA3—head—atopic dermatitis	0.0155	0.0613	CbGeAlD
Glycine—SLC6A9—head—atopic dermatitis	0.0155	0.0613	CbGeAlD
Glycine—GCAT—skin of body—atopic dermatitis	0.0145	0.0574	CbGeAlD
Glycine—GCSH—head—atopic dermatitis	0.0126	0.0499	CbGeAlD
Glycine—GARS—skin of body—atopic dermatitis	0.0116	0.0459	CbGeAlD
Glycine—GLRA2—head—atopic dermatitis	0.0107	0.0425	CbGeAlD
Glycine—GLDC—head—atopic dermatitis	0.0105	0.0414	CbGeAlD
Glycine—SHMT2—skin of body—atopic dermatitis	0.0101	0.0399	CbGeAlD
Glycine—GLRA3—Ion channel transport—TRPV3—atopic dermatitis	0.00993	0.0335	CbGpPWpGaD
Glycine—GLRA2—Ion channel transport—TRPV3—atopic dermatitis	0.00993	0.0335	CbGpPWpGaD
Glycine—PIPOX—head—atopic dermatitis	0.00978	0.0386	CbGeAlD
Glycine—GCAT—head—atopic dermatitis	0.00948	0.0375	CbGeAlD
Glycine—Acidosis—Tacrolimus—atopic dermatitis	0.00937	0.0221	CcSEcCtD
Glycine—Cardiovascular disorder—Loratadine—atopic dermatitis	0.00864	0.0204	CcSEcCtD
Glycine—Fluid overload—Tacrolimus—atopic dermatitis	0.00834	0.0197	CcSEcCtD
Glycine—ALAS1—head—atopic dermatitis	0.00831	0.0329	CbGeAlD
Glycine—GLRB—Ion channel transport—TRPV3—atopic dermatitis	0.00809	0.0273	CbGpPWpGaD
Glycine—Encephalopathy—Tacrolimus—atopic dermatitis	0.00808	0.0191	CcSEcCtD
Glycine—SLC16A10—neck—atopic dermatitis	0.00781	0.0309	CbGeAlD
Glycine—Electrolyte imbalance—Hydrocortisone—atopic dermatitis	0.00775	0.0183	CcSEcCtD
Glycine—GARS—head—atopic dermatitis	0.00757	0.0299	CbGeAlD
Glycine—GRIN2C—head—atopic dermatitis	0.00745	0.0294	CbGeAlD
Glycine—Salivary hypersecretion—Loratadine—atopic dermatitis	0.00737	0.0174	CcSEcCtD
Glycine—Lung disorder—Tacrolimus—atopic dermatitis	0.00733	0.0173	CcSEcCtD
Glycine—Electrolyte imbalance—Methylprednisolone—atopic dermatitis	0.00728	0.0172	CcSEcCtD
Glycine—GATM—head—atopic dermatitis	0.00719	0.0284	CbGeAlD
Glycine—AGXT2—Nucleotide metabolism—ADSL—atopic dermatitis	0.00709	0.024	CbGpPWpGaD
Glycine—GSS—skin of body—atopic dermatitis	0.0069	0.0273	CbGeAlD
Glycine—Urinary retention—Diphenhydramine—atopic dermatitis	0.00681	0.016	CcSEcCtD
Glycine—Urinary retention—Dimenhydrinate—atopic dermatitis	0.00681	0.016	CcSEcCtD
Glycine—Electrolyte imbalance—Dexamethasone—atopic dermatitis	0.00662	0.0156	CcSEcCtD
Glycine—Electrolyte imbalance—Betamethasone—atopic dermatitis	0.00662	0.0156	CcSEcCtD
Glycine—SHMT2—head—atopic dermatitis	0.00659	0.026	CbGeAlD
Glycine—SLC6A9—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.00646	0.0218	CbGpPWpGaD
Glycine—SLC6A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.00646	0.0218	CbGpPWpGaD
Glycine—GLRA1—Ion channel transport—TRPV3—atopic dermatitis	0.0064	0.0216	CbGpPWpGaD
Glycine—GLRB—head—atopic dermatitis	0.00617	0.0244	CbGeAlD
Glycine—SHMT1—head—atopic dermatitis	0.006	0.0237	CbGeAlD
Glycine—Cardiovascular disorder—Tacrolimus—atopic dermatitis	0.0059	0.0139	CcSEcCtD
Glycine—SHMT2—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.0054	0.0182	CbGpPWpGaD
Glycine—Visual disturbance—Fluocinolone Acetonide—atopic dermatitis	0.00523	0.0123	CcSEcCtD
Glycine—GRIN2A—head—atopic dermatitis	0.00515	0.0203	CbGeAlD
Glycine—SLC36A1—head—atopic dermatitis	0.00511	0.0202	CbGeAlD
Glycine—GPR18—GPCRs, Other—CXCR3—atopic dermatitis	0.00488	0.0165	CbGpPWpGaD
Glycine—Rhinitis—Pimecrolimus—atopic dermatitis	0.0048	0.0113	CcSEcCtD
Glycine—Coma—Tacrolimus—atopic dermatitis	0.00474	0.0112	CcSEcCtD
Glycine—GSS—head—atopic dermatitis	0.0045	0.0178	CbGeAlD
Glycine—Chills—Diphenhydramine—atopic dermatitis	0.00444	0.0105	CcSEcCtD
Glycine—Chills—Dimenhydrinate—atopic dermatitis	0.00444	0.0105	CcSEcCtD
Glycine—GPR18—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00444	0.015	CbGpPWpGaD
Glycine—Thrombophlebitis—Tacrolimus—atopic dermatitis	0.00435	0.0103	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—IL4—atopic dermatitis	0.00426	0.0144	CbGpPWpGaD
Glycine—ALAS1—Transcriptional activation of mitochondrial biogenesis—PPARA—atopic dermatitis	0.00425	0.0143	CbGpPWpGaD
Glycine—Pain—Desonide—atopic dermatitis	0.00412	0.00971	CcSEcCtD
Glycine—SLC6A5—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00406	0.0137	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00406	0.0137	CbGpPWpGaD
Glycine—Vision blurred—Diphenhydramine—atopic dermatitis	0.00406	0.00958	CcSEcCtD
Glycine—Vision blurred—Dimenhydrinate—atopic dermatitis	0.00406	0.00958	CcSEcCtD
Glycine—Back pain—Pimecrolimus—atopic dermatitis	0.00403	0.00951	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00396	0.0134	CbGpPWpGaD
Glycine—Thirst—Tacrolimus—atopic dermatitis	0.00396	0.00933	CcSEcCtD
Glycine—Vertigo—Dimenhydrinate—atopic dermatitis	0.00387	0.00913	CcSEcCtD
Glycine—Vertigo—Diphenhydramine—atopic dermatitis	0.00387	0.00913	CcSEcCtD
Glycine—Hyponatraemia—Tacrolimus—atopic dermatitis	0.00378	0.00891	CcSEcCtD
Glycine—Convulsion—Dimenhydrinate—atopic dermatitis	0.00373	0.00881	CcSEcCtD
Glycine—Convulsion—Diphenhydramine—atopic dermatitis	0.00373	0.00881	CcSEcCtD
Glycine—ALAS1—Mitochondrial biogenesis—PPARA—atopic dermatitis	0.00367	0.0124	CbGpPWpGaD
Glycine—Urinary retention—Tacrolimus—atopic dermatitis	0.00358	0.00844	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00353	0.0119	CbGpPWpGaD
Glycine—Dehydration—Tacrolimus—atopic dermatitis	0.0035	0.00826	CcSEcCtD
Glycine—GLRA2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00346	0.0117	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00346	0.0117	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00346	0.0117	CbGpPWpGaD
Glycine—Rhinitis—Fluocinolone Acetonide—atopic dermatitis	0.00344	0.0081	CcSEcCtD
Glycine—Tachycardia—Diphenhydramine—atopic dermatitis	0.00343	0.0081	CcSEcCtD
Glycine—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00343	0.0081	CcSEcCtD
Glycine—Oedema—Pimecrolimus—atopic dermatitis	0.0034	0.00802	CcSEcCtD
Glycine—Pain—Fluocinonide—atopic dermatitis	0.00334	0.00787	CcSEcCtD
Glycine—Visual impairment—Fluocinolone Acetonide—atopic dermatitis	0.0033	0.00779	CcSEcCtD
Glycine—Hypotension—Dimenhydrinate—atopic dermatitis	0.00329	0.00775	CcSEcCtD
Glycine—Hypotension—Diphenhydramine—atopic dermatitis	0.00329	0.00775	CcSEcCtD
Glycine—Rhinitis—Mometasone—atopic dermatitis	0.00328	0.00774	CcSEcCtD
Glycine—Angina pectoris—Tacrolimus—atopic dermatitis	0.00317	0.00748	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00317	0.0107	CbGpPWpGaD
Glycine—SHMT2—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.00316	0.0107	CbGpPWpGaD
Glycine—GPR18—GPCRs, Other—CCR5—atopic dermatitis	0.00306	0.0103	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CCL22—atopic dermatitis	0.00302	0.0102	CbGpPWpGaD
Glycine—SLC6A5—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.00294	0.00992	CbGpPWpGaD
Glycine—SLC6A9—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.00294	0.00992	CbGpPWpGaD
Glycine—Pain—Pimecrolimus—atopic dermatitis	0.00291	0.00686	CcSEcCtD
Glycine—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.00289	0.00681	CcSEcCtD
Glycine—Hypersensitivity—Fluocinonide—atopic dermatitis	0.00287	0.00678	CcSEcCtD
Glycine—SHMT2—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.00282	0.00953	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00282	0.00952	CbGpPWpGaD
Glycine—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.00281	0.00663	CcSEcCtD
Glycine—Urticaria—Dimenhydrinate—atopic dermatitis	0.00279	0.00659	CcSEcCtD
Glycine—Urticaria—Diphenhydramine—atopic dermatitis	0.00279	0.00659	CcSEcCtD
Glycine—Thrombophlebitis—Prednisolone—atopic dermatitis	0.00278	0.00655	CcSEcCtD
Glycine—Back pain—Mometasone—atopic dermatitis	0.00276	0.0065	CcSEcCtD
Glycine—Thrombophlebitis—Hydrocortisone—atopic dermatitis	0.00271	0.0064	CcSEcCtD
Glycine—Urticaria—Pimecrolimus—atopic dermatitis	0.0027	0.00637	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CCL27—atopic dermatitis	0.00269	0.00908	CbGpPWpGaD
Glycine—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.00268	0.00632	CcSEcCtD
Glycine—Tachycardia—Loratadine—atopic dermatitis	0.00264	0.00624	CcSEcCtD
Glycine—GPR18—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00262	0.00884	CbGpPWpGaD
Glycine—Rhinitis—Tacrolimus—atopic dermatitis	0.00261	0.00616	CcSEcCtD
Glycine—Dizziness—Fluocinonide—atopic dermatitis	0.00258	0.00608	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—IFNG—atopic dermatitis	0.00257	0.0087	CbGpPWpGaD
Glycine—Thrombophlebitis—Triamcinolone—atopic dermatitis	0.00255	0.00602	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00255	0.00862	CbGpPWpGaD
Glycine—Thrombophlebitis—Methylprednisolone—atopic dermatitis	0.00255	0.00601	CcSEcCtD
Glycine—Visual disturbance—Prednisolone—atopic dermatitis	0.00254	0.00598	CcSEcCtD
Glycine—Hypotension—Loratadine—atopic dermatitis	0.00253	0.00597	CcSEcCtD
Glycine—SHMT1—Folate Metabolism—IL4—atopic dermatitis	0.00251	0.00848	CbGpPWpGaD
Glycine—Visual impairment—Tacrolimus—atopic dermatitis	0.00251	0.00592	CcSEcCtD
Glycine—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.00251	0.00591	CcSEcCtD
Glycine—SLC32A1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.0025	0.00843	CbGpPWpGaD
Glycine—Oedema—Fluocinolone Acetonide—atopic dermatitis	0.00243	0.00574	CcSEcCtD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00243	0.0082	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CCL17—atopic dermatitis	0.00241	0.00814	CbGpPWpGaD
Glycine—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00241	0.00568	CcSEcCtD
Glycine—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00241	0.00568	CcSEcCtD
Glycine—Chills—Tacrolimus—atopic dermatitis	0.00234	0.00551	CcSEcCtD
Glycine—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00233	0.00549	CcSEcCtD
Glycine—Dizziness—Dimenhydrinate—atopic dermatitis	0.00233	0.00549	CcSEcCtD
Glycine—Dizziness—Diphenhydramine—atopic dermatitis	0.00233	0.00549	CcSEcCtD
Glycine—Thrombophlebitis—Dexamethasone—atopic dermatitis	0.00232	0.00547	CcSEcCtD
Glycine—Thrombophlebitis—Betamethasone—atopic dermatitis	0.00232	0.00547	CcSEcCtD
Glycine—Pain—Loratadine—atopic dermatitis	0.00232	0.00546	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—IL1B—atopic dermatitis	0.0023	0.00776	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—IL2—atopic dermatitis	0.00229	0.00773	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00229	0.00773	CbGpPWpGaD
Glycine—Vomiting—Dimenhydrinate—atopic dermatitis	0.00224	0.00527	CcSEcCtD
Glycine—Vomiting—Diphenhydramine—atopic dermatitis	0.00224	0.00527	CcSEcCtD
Glycine—GLRA1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00223	0.00752	CbGpPWpGaD
Glycine—Back pain—Tacrolimus—atopic dermatitis	0.00219	0.00517	CcSEcCtD
Glycine—Vomiting—Pimecrolimus—atopic dermatitis	0.00216	0.0051	CcSEcCtD
Glycine—Vision blurred—Tacrolimus—atopic dermatitis	0.00214	0.00504	CcSEcCtD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00212	0.00717	CbGpPWpGaD
Glycine—Visual disturbance—Dexamethasone—atopic dermatitis	0.00212	0.00499	CcSEcCtD
Glycine—Visual disturbance—Betamethasone—atopic dermatitis	0.00212	0.00499	CcSEcCtD
Glycine—Nausea—Dimenhydrinate—atopic dermatitis	0.00209	0.00493	CcSEcCtD
Glycine—Nausea—Diphenhydramine—atopic dermatitis	0.00209	0.00493	CcSEcCtD
Glycine—Pain—Fluocinolone Acetonide—atopic dermatitis	0.00208	0.00491	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00208	0.00703	CbGpPWpGaD
Glycine—ALAS1—PPARA activates gene expression—PPARA—atopic dermatitis	0.00208	0.00702	CbGpPWpGaD
Glycine—SHMT2—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.00205	0.00692	CbGpPWpGaD
Glycine—ALAS1—Budesonide—Desonide—atopic dermatitis	0.00204	0.076	CbGdCrCtD
Glycine—Vertigo—Tacrolimus—atopic dermatitis	0.00204	0.0048	CcSEcCtD
Glycine—ALAS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	0.00203	0.00687	CbGpPWpGaD
Glycine—Nausea—Pimecrolimus—atopic dermatitis	0.00202	0.00476	CcSEcCtD
Glycine—Thrombophlebitis—Prednisone—atopic dermatitis	0.00202	0.00476	CcSEcCtD
Glycine—BAAT—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00199	0.00673	CbGpPWpGaD
Glycine—Pain—Mometasone—atopic dermatitis	0.00199	0.00469	CcSEcCtD
Glycine—SLC36A1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00198	0.00671	CbGpPWpGaD
Glycine—Convulsion—Tacrolimus—atopic dermatitis	0.00196	0.00463	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CCL11—atopic dermatitis	0.00194	0.00656	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00185	0.00626	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00185	0.00626	CbGpPWpGaD
Glycine—Diarrhoea—Loratadine—atopic dermatitis	0.00185	0.00437	CcSEcCtD
Glycine—Oedema—Tacrolimus—atopic dermatitis	0.00185	0.00436	CcSEcCtD
Glycine—GPR18—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00185	0.00624	CbGpPWpGaD
Glycine—ALAS1—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.00183	0.0679	CbGdCrCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00182	0.00614	CbGpPWpGaD
Glycine—Tachycardia—Tacrolimus—atopic dermatitis	0.00181	0.00426	CcSEcCtD
Glycine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00179	0.00423	CcSEcCtD
Glycine—Dizziness—Loratadine—atopic dermatitis	0.00179	0.00422	CcSEcCtD
Glycine—Hypotension—Tacrolimus—atopic dermatitis	0.00173	0.00408	CcSEcCtD
Glycine—Vomiting—Loratadine—atopic dermatitis	0.00172	0.00406	CcSEcCtD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00172	0.00581	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—TNF—atopic dermatitis	0.00167	0.00563	CbGpPWpGaD
Glycine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00167	0.00393	CcSEcCtD
Glycine—ALAS1—Organelle biogenesis and maintenance—PPARA—atopic dermatitis	0.00167	0.00563	CbGpPWpGaD
Glycine—SHMT2—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.00165	0.00558	CbGpPWpGaD
Glycine—ALAS1—Budesonide—Fluocinonide—atopic dermatitis	0.00164	0.0608	CbGdCrCtD
Glycine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00161	0.0038	CcSEcCtD
Glycine—Nausea—Loratadine—atopic dermatitis	0.00161	0.00379	CcSEcCtD
Glycine—Visual impairment—Prednisolone—atopic dermatitis	0.0016	0.00378	CcSEcCtD
Glycine—GPR18—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00159	0.00538	CbGpPWpGaD
Glycine—Diarrhoea—Mometasone—atopic dermatitis	0.00159	0.00375	CcSEcCtD
Glycine—ALAS1—Budesonide—Fluocinolone Acetonide—atopic dermatitis	0.00159	0.0591	CbGdCrCtD
Glycine—GPR18—GPCR ligand binding—CCR3—atopic dermatitis	0.00158	0.00535	CbGpPWpGaD
Glycine—Pain—Tacrolimus—atopic dermatitis	0.00158	0.00373	CcSEcCtD
Glycine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00155	0.00365	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CCL22—atopic dermatitis	0.00155	0.00523	CbGpPWpGaD
Glycine—Rhinitis—Triamcinolone—atopic dermatitis	0.00153	0.00362	CcSEcCtD
Glycine—Rhinitis—Methylprednisolone—atopic dermatitis	0.00153	0.00361	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—CCL27—atopic dermatitis	0.00152	0.00513	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—IFNG—atopic dermatitis	0.00152	0.00513	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00149	0.00504	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00149	0.00504	CbGpPWpGaD
Glycine—Vomiting—Mometasone—atopic dermatitis	0.00148	0.00349	CcSEcCtD
Glycine—GRIN2A—Reelin signaling pathway—MAPK8—atopic dermatitis	0.00148	0.00499	CbGpPWpGaD
Glycine—Visual impairment—Methylprednisolone—atopic dermatitis	0.00147	0.00347	CcSEcCtD
Glycine—Urticaria—Tacrolimus—atopic dermatitis	0.00147	0.00347	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00147	0.00497	CbGpPWpGaD
Glycine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00145	0.00341	CcSEcCtD
Glycine—SLC36A1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.00143	0.00484	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00143	0.00484	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—TAC1—atopic dermatitis	0.00141	0.00477	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—NPS—atopic dermatitis	0.00141	0.00477	CbGpPWpGaD
Glycine—ALAS1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.0014	0.00473	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CXCR3—atopic dermatitis	0.00138	0.00468	CbGpPWpGaD
Glycine—Nausea—Mometasone—atopic dermatitis	0.00138	0.00326	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CCL27—atopic dermatitis	0.00138	0.00466	CbGpPWpGaD
Glycine—Vision blurred—Prednisolone—atopic dermatitis	0.00136	0.00322	CcSEcCtD
Glycine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00136	0.00322	CcSEcCtD
Glycine—SHMT1—Folate Metabolism—IL1B—atopic dermatitis	0.00135	0.00457	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—IL2—atopic dermatitis	0.00135	0.00455	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—IL6—atopic dermatitis	0.00134	0.00454	CbGpPWpGaD
Glycine—Visual impairment—Betamethasone—atopic dermatitis	0.00134	0.00315	CcSEcCtD
Glycine—Visual impairment—Dexamethasone—atopic dermatitis	0.00134	0.00315	CcSEcCtD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00133	0.00449	CbGpPWpGaD
Glycine—Vertigo—Prednisolone—atopic dermatitis	0.0013	0.00307	CcSEcCtD
Glycine—Back pain—Triamcinolone—atopic dermatitis	0.00129	0.00304	CcSEcCtD
Glycine—Vertigo—Hydrocortisone—atopic dermatitis	0.00127	0.003	CcSEcCtD
Glycine—ALAS1—Budesonide—Mometasone—atopic dermatitis	0.00127	0.0472	CbGdCrCtD
Glycine—GLRA2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00127	0.00429	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00127	0.00429	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00127	0.00429	CbGpPWpGaD
Glycine—Diarrhoea—Tacrolimus—atopic dermatitis	0.00127	0.00299	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00127	0.00427	CbGpPWpGaD
Glycine—Convulsion—Prednisolone—atopic dermatitis	0.00125	0.00296	CcSEcCtD
Glycine—ALAS1—Betamethasone—Desonide—atopic dermatitis	0.00125	0.0465	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Desonide—atopic dermatitis	0.00125	0.0465	CbGdCrCtD
Glycine—GPR18—Signaling by GPCR—CCL17—atopic dermatitis	0.00124	0.00418	CbGpPWpGaD
Glycine—ALAS2—Metabolism—GLB1—atopic dermatitis	0.00123	0.00414	CbGpPWpGaD
Glycine—Convulsion—Hydrocortisone—atopic dermatitis	0.00123	0.00289	CcSEcCtD
Glycine—Dizziness—Tacrolimus—atopic dermatitis	0.00122	0.00289	CcSEcCtD
Glycine—GRIN2C—Alzheimers Disease—CASP8—atopic dermatitis	0.00121	0.0041	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00121	0.00408	CbGpPWpGaD
Glycine—Vertigo—Triamcinolone—atopic dermatitis	0.0012	0.00282	CcSEcCtD
Glycine—Vertigo—Methylprednisolone—atopic dermatitis	0.00119	0.00282	CcSEcCtD
Glycine—Oedema—Prednisolone—atopic dermatitis	0.00118	0.00279	CcSEcCtD
Glycine—Vomiting—Tacrolimus—atopic dermatitis	0.00118	0.00277	CcSEcCtD
Glycine—ALAS2—Metabolism—ADSL—atopic dermatitis	0.00118	0.00397	CbGpPWpGaD
Glycine—Oedema—Hydrocortisone—atopic dermatitis	0.00115	0.00272	CcSEcCtD
Glycine—Convulsion—Triamcinolone—atopic dermatitis	0.00115	0.00272	CcSEcCtD
Glycine—Tachycardia—Prednisolone—atopic dermatitis	0.00115	0.00272	CcSEcCtD
Glycine—Convulsion—Methylprednisolone—atopic dermatitis	0.00115	0.00272	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00114	0.00385	CbGpPWpGaD
Glycine—Tachycardia—Hydrocortisone—atopic dermatitis	0.00113	0.00266	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CXCL10—atopic dermatitis	0.00112	0.00378	CbGpPWpGaD
Glycine—Nausea—Tacrolimus—atopic dermatitis	0.0011	0.00259	CcSEcCtD
Glycine—Oedema—Triamcinolone—atopic dermatitis	0.00109	0.00256	CcSEcCtD
Glycine—Vertigo—Dexamethasone—atopic dermatitis	0.00109	0.00256	CcSEcCtD
Glycine—Vertigo—Betamethasone—atopic dermatitis	0.00109	0.00256	CcSEcCtD
Glycine—Hypotension—Hydrocortisone—atopic dermatitis	0.00108	0.00254	CcSEcCtD
Glycine—Tachycardia—Triamcinolone—atopic dermatitis	0.00106	0.0025	CcSEcCtD
Glycine—Tachycardia—Methylprednisolone—atopic dermatitis	0.00106	0.0025	CcSEcCtD
Glycine—Convulsion—Betamethasone—atopic dermatitis	0.00105	0.00247	CcSEcCtD
Glycine—Convulsion—Dexamethasone—atopic dermatitis	0.00105	0.00247	CcSEcCtD
Glycine—GLRB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00103	0.00349	CbGpPWpGaD
Glycine—Hypotension—Methylprednisolone—atopic dermatitis	0.00101	0.00239	CcSEcCtD
Glycine—Pain—Prednisolone—atopic dermatitis	0.00101	0.00238	CcSEcCtD
Glycine—ALAS1—Betamethasone—Fluocinonide—atopic dermatitis	0.001	0.0372	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Fluocinonide—atopic dermatitis	0.001	0.0372	CbGdCrCtD
Glycine—GPR18—Signaling by GPCR—CCL11—atopic dermatitis	0.000997	0.00337	CbGpPWpGaD
Glycine—Vision blurred—Prednisone—atopic dermatitis	0.000992	0.00234	CcSEcCtD
Glycine—Pain—Hydrocortisone—atopic dermatitis	0.000987	0.00233	CcSEcCtD
Glycine—Oedema—Betamethasone—atopic dermatitis	0.000986	0.00233	CcSEcCtD
Glycine—Oedema—Dexamethasone—atopic dermatitis	0.000986	0.00233	CcSEcCtD
Glycine—GPR18—Signaling Pathways—FCER2—atopic dermatitis	0.000983	0.00332	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TNF—atopic dermatitis	0.000982	0.00332	CbGpPWpGaD
Glycine—ALAS1—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000973	0.0362	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000973	0.0362	CbGdCrCtD
Glycine—GPR18—GPCR ligand binding—CCL5—atopic dermatitis	0.000963	0.00325	CbGpPWpGaD
Glycine—Tachycardia—Betamethasone—atopic dermatitis	0.000963	0.00227	CcSEcCtD
Glycine—Tachycardia—Dexamethasone—atopic dermatitis	0.000963	0.00227	CcSEcCtD
Glycine—Vertigo—Prednisone—atopic dermatitis	0.000945	0.00223	CcSEcCtD
Glycine—Urticaria—Prednisolone—atopic dermatitis	0.000939	0.00221	CcSEcCtD
Glycine—GLYATL2—Metabolism—GLB1—atopic dermatitis	0.00093	0.00314	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GLB1—atopic dermatitis	0.00093	0.00314	CbGpPWpGaD
Glycine—GATM—Metabolism—GLB1—atopic dermatitis	0.00093	0.00314	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GLB1—atopic dermatitis	0.00093	0.00314	CbGpPWpGaD
Glycine—Pain—Triamcinolone—atopic dermatitis	0.000929	0.00219	CcSEcCtD
Glycine—GRIN2A—Alzheimers Disease—CASP8—atopic dermatitis	0.000926	0.00313	CbGpPWpGaD
Glycine—Hypotension—Dexamethasone—atopic dermatitis	0.000922	0.00217	CcSEcCtD
Glycine—Hypotension—Betamethasone—atopic dermatitis	0.000922	0.00217	CcSEcCtD
Glycine—GRIN2C—Alzheimers Disease—IL1B—atopic dermatitis	0.00092	0.00311	CbGpPWpGaD
Glycine—Urticaria—Hydrocortisone—atopic dermatitis	0.000917	0.00216	CcSEcCtD
Glycine—GPR18—Signaling Pathways—CCL22—atopic dermatitis	0.000914	0.00309	CbGpPWpGaD
Glycine—Convulsion—Prednisone—atopic dermatitis	0.000912	0.00215	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—CCR3—atopic dermatitis	0.000895	0.00302	CbGpPWpGaD
Glycine—GATM—Metabolism—ADSL—atopic dermatitis	0.000891	0.00301	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ADSL—atopic dermatitis	0.000891	0.00301	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ADSL—atopic dermatitis	0.000891	0.00301	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ADSL—atopic dermatitis	0.000891	0.00301	CbGpPWpGaD
Glycine—BAAT—Metabolism—GLB1—atopic dermatitis	0.000887	0.003	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000871	0.00294	CbGpPWpGaD
Glycine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000871	0.00205	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CCR5—atopic dermatitis	0.000868	0.00293	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000867	0.00293	CbGpPWpGaD
Glycine—Urticaria—Triamcinolone—atopic dermatitis	0.000863	0.00204	CcSEcCtD
Glycine—Urticaria—Methylprednisolone—atopic dermatitis	0.000862	0.00203	CcSEcCtD
Glycine—Oedema—Prednisone—atopic dermatitis	0.000859	0.00203	CcSEcCtD
Glycine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.00085	0.00201	CcSEcCtD
Glycine—BAAT—Metabolism—ADSL—atopic dermatitis	0.00085	0.00287	CbGpPWpGaD
Glycine—Pain—Betamethasone—atopic dermatitis	0.000843	0.00199	CcSEcCtD
Glycine—Pain—Dexamethasone—atopic dermatitis	0.000843	0.00199	CcSEcCtD
Glycine—Tachycardia—Prednisone—atopic dermatitis	0.000838	0.00198	CcSEcCtD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000817	0.00276	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL27—atopic dermatitis	0.000815	0.00275	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCR3—atopic dermatitis	0.000813	0.00275	CbGpPWpGaD
Glycine—ALAS1—Budesonide—Hydrocortisone—atopic dermatitis	0.000803	0.0299	CbGdCrCtD
Glycine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000801	0.00189	CcSEcCtD
Glycine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000799	0.00188	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—TAC1—atopic dermatitis	0.000798	0.0027	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—NPS—atopic dermatitis	0.000798	0.0027	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—IL6—atopic dermatitis	0.000792	0.00268	CbGpPWpGaD
Glycine—AGXT—Metabolism—GLB1—atopic dermatitis	0.00079	0.00267	CbGpPWpGaD
Glycine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00079	0.00186	CcSEcCtD
Glycine—Urticaria—Dexamethasone—atopic dermatitis	0.000783	0.00185	CcSEcCtD
Glycine—Urticaria—Betamethasone—atopic dermatitis	0.000783	0.00185	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000782	0.00264	CbGpPWpGaD
Glycine—Dizziness—Prednisolone—atopic dermatitis	0.000782	0.00184	CcSEcCtD
Glycine—ALAS1—Dexamethasone—Mometasone—atopic dermatitis	0.000776	0.0289	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Mometasone—atopic dermatitis	0.000776	0.0289	CbGdCrCtD
Glycine—ALAS1—Metabolism—GLB1—atopic dermatitis	0.000766	0.00259	CbGpPWpGaD
Glycine—Dizziness—Hydrocortisone—atopic dermatitis	0.000763	0.0018	CcSEcCtD
Glycine—ALAS1—Budesonide—Methylprednisolone—atopic dermatitis	0.000758	0.0282	CbGdCrCtD
Glycine—AGXT—Metabolism—ADSL—atopic dermatitis	0.000758	0.00256	CbGpPWpGaD
Glycine—ALAS1—Budesonide—Betamethasone—atopic dermatitis	0.000746	0.0277	CbGdCrCtD
Glycine—ALAS1—Budesonide—Dexamethasone—atopic dermatitis	0.000746	0.0277	CbGdCrCtD
Glycine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000742	0.00175	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—IL5—atopic dermatitis	0.000742	0.00251	CbGpPWpGaD
Glycine—Vomiting—Hydrocortisone—atopic dermatitis	0.000734	0.00173	CcSEcCtD
Glycine—ALAS1—Metabolism—ADSL—atopic dermatitis	0.000734	0.00248	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL17—atopic dermatitis	0.000731	0.00247	CbGpPWpGaD
Glycine—ALAS1—Budesonide—Triamcinolone—atopic dermatitis	0.000729	0.0271	CbGdCrCtD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000729	0.00246	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—TAC1—atopic dermatitis	0.000725	0.00245	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NPS—atopic dermatitis	0.000725	0.00245	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000723	0.00244	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000723	0.00244	CbGpPWpGaD
Glycine—Dizziness—Triamcinolone—atopic dermatitis	0.000719	0.0017	CcSEcCtD
Glycine—Dizziness—Methylprednisolone—atopic dermatitis	0.000717	0.00169	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CXCR3—atopic dermatitis	0.000711	0.0024	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—IL1B—atopic dermatitis	0.000702	0.00237	CbGpPWpGaD
Glycine—Nausea—Prednisolone—atopic dermatitis	0.000702	0.00166	CcSEcCtD
Glycine—ALAS1—Budesonide—Prednisone—atopic dermatitis	0.000692	0.0257	CbGdCrCtD
Glycine—Vomiting—Triamcinolone—atopic dermatitis	0.000691	0.00163	CcSEcCtD
Glycine—Vomiting—Methylprednisolone—atopic dermatitis	0.00069	0.00163	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000689	0.00233	CbGpPWpGaD
Glycine—Nausea—Hydrocortisone—atopic dermatitis	0.000686	0.00162	CcSEcCtD
Glycine—Urticaria—Prednisone—atopic dermatitis	0.000682	0.00161	CcSEcCtD
Glycine—ALAS1—Budesonide—Prednisolone—atopic dermatitis	0.000675	0.0251	CbGdCrCtD
Glycine—Diarrhoea—Betamethasone—atopic dermatitis	0.000675	0.00159	CcSEcCtD
Glycine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000675	0.00159	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—IL5—atopic dermatitis	0.000674	0.00228	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GLB1—atopic dermatitis	0.000672	0.00227	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TNF—atopic dermatitis	0.000667	0.00225	CbGpPWpGaD
Glycine—SHMT1—Disease—GLB1—atopic dermatitis	0.000654	0.00221	CbGpPWpGaD
Glycine—Dizziness—Dexamethasone—atopic dermatitis	0.000652	0.00154	CcSEcCtD
Glycine—Dizziness—Betamethasone—atopic dermatitis	0.000652	0.00154	CcSEcCtD
Glycine—GPR18—Signaling Pathways—KIF3A—atopic dermatitis	0.000651	0.0022	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000646	0.00218	CbGpPWpGaD
Glycine—Nausea—Triamcinolone—atopic dermatitis	0.000646	0.00152	CcSEcCtD
Glycine—AGXT2—Metabolism—ADSL—atopic dermatitis	0.000644	0.00218	CbGpPWpGaD
Glycine—Nausea—Methylprednisolone—atopic dermatitis	0.000644	0.00152	CcSEcCtD
Glycine—Hypersensitivity—Prednisone—atopic dermatitis	0.000633	0.00149	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000632	0.00214	CbGpPWpGaD
Glycine—Vomiting—Betamethasone—atopic dermatitis	0.000627	0.00148	CcSEcCtD
Glycine—Vomiting—Dexamethasone—atopic dermatitis	0.000627	0.00148	CcSEcCtD
Glycine—SLC32A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000614	0.00208	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000614	0.00208	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000614	0.00208	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CMA1—atopic dermatitis	0.000589	0.00199	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL11—atopic dermatitis	0.000589	0.00199	CbGpPWpGaD
Glycine—Diarrhoea—Prednisone—atopic dermatitis	0.000588	0.00139	CcSEcCtD
Glycine—Nausea—Dexamethasone—atopic dermatitis	0.000586	0.00138	CcSEcCtD
Glycine—Nausea—Betamethasone—atopic dermatitis	0.000586	0.00138	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CXCL10—atopic dermatitis	0.000574	0.00194	CbGpPWpGaD
Glycine—Dizziness—Prednisone—atopic dermatitis	0.000568	0.00134	CcSEcCtD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000558	0.00188	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT6—atopic dermatitis	0.000554	0.00187	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GLB1—atopic dermatitis	0.000548	0.00185	CbGpPWpGaD
Glycine—Vomiting—Prednisone—atopic dermatitis	0.000546	0.00129	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—CCL5—atopic dermatitis	0.000544	0.00184	CbGpPWpGaD
Glycine—GSS—Metabolism—GLB1—atopic dermatitis	0.000534	0.0018	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ADSL—atopic dermatitis	0.000525	0.00177	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CXCL8—atopic dermatitis	0.000525	0.00177	CbGpPWpGaD
Glycine—GARS—Gene Expression—PPARA—atopic dermatitis	0.000512	0.00173	CbGpPWpGaD
Glycine—GSS—Metabolism—ADSL—atopic dermatitis	0.000512	0.00173	CbGpPWpGaD
Glycine—Nausea—Prednisone—atopic dermatitis	0.00051	0.0012	CcSEcCtD
Glycine—GRIN2A—Alzheimers Disease—TNF—atopic dermatitis	0.000509	0.00172	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000501	0.00169	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCL5—atopic dermatitis	0.000494	0.00167	CbGpPWpGaD
Glycine—ALAS1—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000491	0.0183	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Hydrocortisone—atopic dermatitis	0.000491	0.0183	CbGdCrCtD
Glycine—GPR18—GPCR downstream signaling—CCR5—atopic dermatitis	0.00049	0.00166	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR3—atopic dermatitis	0.00048	0.00162	CbGpPWpGaD
Glycine—ALAS1—Betamethasone—Methylprednisolone—atopic dermatitis	0.000464	0.0172	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Methylprednisolone—atopic dermatitis	0.000464	0.0172	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Betamethasone—atopic dermatitis	0.000456	0.017	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Dexamethasone—atopic dermatitis	0.000456	0.017	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Triamcinolone—atopic dermatitis	0.000446	0.0166	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Triamcinolone—atopic dermatitis	0.000446	0.0166	CbGdCrCtD
Glycine—GPR18—Signaling by GPCR—CCR5—atopic dermatitis	0.000445	0.0015	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000443	0.0015	CbGpPWpGaD
Glycine—SHMT1—Disease—SLC11A1—atopic dermatitis	0.000438	0.00148	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NPS—atopic dermatitis	0.000428	0.00145	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TAC1—atopic dermatitis	0.000428	0.00145	CbGpPWpGaD
Glycine—ALAS1—Betamethasone—Prednisone—atopic dermatitis	0.000423	0.0157	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Prednisone—atopic dermatitis	0.000423	0.0157	CbGdCrCtD
Glycine—GPR18—Signaling Pathways—CXCR3—atopic dermatitis	0.00042	0.00142	CbGpPWpGaD
Glycine—ALAS1—Dexamethasone—Prednisolone—atopic dermatitis	0.000413	0.0154	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Prednisolone—atopic dermatitis	0.000413	0.0154	CbGdCrCtD
Glycine—ALAS2—Metabolism—PPARA—atopic dermatitis	0.000398	0.00134	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL5—atopic dermatitis	0.000398	0.00134	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000396	0.00134	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000353	0.00119	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL10—atopic dermatitis	0.000339	0.00115	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PPARA—atopic dermatitis	0.000302	0.00102	CbGpPWpGaD
Glycine—GATM—Metabolism—PPARA—atopic dermatitis	0.000302	0.00102	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PPARA—atopic dermatitis	0.000302	0.00102	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPARA—atopic dermatitis	0.000302	0.00102	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000297	0.001	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL5—atopic dermatitis	0.000292	0.000987	CbGpPWpGaD
Glycine—BAAT—Metabolism—PPARA—atopic dermatitis	0.000288	0.000972	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—atopic dermatitis	0.000283	0.000957	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NGF—atopic dermatitis	0.00027	0.000914	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCL8—atopic dermatitis	0.000269	0.00091	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR5—atopic dermatitis	0.000263	0.000889	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—atopic dermatitis	0.000257	0.000869	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPARA—atopic dermatitis	0.000257	0.000867	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARA—atopic dermatitis	0.000248	0.000839	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NFKBIA—atopic dermatitis	0.000223	0.000754	CbGpPWpGaD
Glycine—SHMT1—Disease—CCR5—atopic dermatitis	0.000221	0.000748	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARA—atopic dermatitis	0.000218	0.000737	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000215	0.000725	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARA—atopic dermatitis	0.000178	0.000601	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARA—atopic dermatitis	0.000173	0.000585	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—atopic dermatitis	0.000159	0.000537	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—atopic dermatitis	0.000152	0.000514	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—atopic dermatitis	0.000151	0.000511	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK8—atopic dermatitis	0.00014	0.000473	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—atopic dermatitis	0.000139	0.00047	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—atopic dermatitis	8.94e-05	0.000302	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—atopic dermatitis	7.52e-05	0.000254	CbGpPWpGaD
